pyrroles has been researched along with zidovudine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holly, M; Hsu, MC; Potash, MJ; Richman, DD; Schutt, AD; Sherman, MI; Slice, LW; Volsky, DJ | 2 |
| Connell, EV; Hsu, MC; Richman, DD | 1 |
| Flexner, C; Ginsberg, R; Hamzeh, FM; Haubrich, RH; Hirsch, M; Lederman, MM; Lietman, P; Pettinelli, CP; Richman, DD; Spector, SA | 1 |
| Bergamini, A; Butini, S; Campiani, G; Catalanotti, B; Coletta, M; De Angelis, M; Fattorusso, C; Fiorini, I; Gemma, S; Greco, G; Huleatt, P; Maga, G; Marini, S; Nacci, V; Novellino, E; Persico, M; Ramunno, A; Rodriquez, M; Spadari, S | 1 |
| Kerr, AL; Pochtarev, V; Steuer, EL; Swain, RA | 1 |
1 trial(s) available for pyrroles and zidovudine
| Article | Year |
|---|---|
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 Team.
Topics: Adult; Antiviral Agents; Benzodiazepines; CD4 Lymphocyte Count; Didanosine; Dose-Response Relationship, Drug; Female; Gene Products, tat; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Time Factors; Zidovudine | 1995 |
5 other study(ies) available for pyrroles and zidovudine
| Article | Year |
|---|---|
Discovery and characterization of an HIV-1 Tat antagonist.
Topics: Animals; Antiviral Agents; Benzodiazepinones; CHO Cells; Cricetinae; Gene Deletion; Gene Expression; Gene Products, tat; Genes, tat; HIV Long Terminal Repeat; HIV-1; HIV-2; Kinetics; Promoter Regions, Genetic; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Virus Replication; Zidovudine | 1992 |
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
Topics: Antiviral Agents; Benzodiazepinones; Cell Line; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; HIV-2; Humans; Kinetics; Promoter Regions, Genetic; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Virus Replication; Zidovudine | 1991 |
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
Topics: Antiviral Agents; Benzodiazepines; Didanosine; Drug Synergism; Gene Products, tat; HeLa Cells; HIV; HIV Protease Inhibitors; Humans; Isoquinolines; Nevirapine; Pyridines; Pyrroles; Quinolines; Reverse Transcriptase Inhibitors; Saquinavir; tat Gene Products, Human Immunodeficiency Virus; Zalcitabine; Zidovudine | 1994 |
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Binding Sites; Cells, Cultured; Conserved Sequence; Drug Design; Drug Resistance, Viral; Drug Synergism; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Mice; Models, Molecular; Mutation; Oxazepines; Pyrroles; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Virus Replication; Zidovudine | 2005 |
Angiogenesis but not neurogenesis is critical for normal learning and memory acquisition.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Indoles; Male; Maze Learning; Memory; Neovascularization, Physiologic; Neurogenesis; Phosphopyruvate Hydratase; Physical Conditioning, Animal; Psychomotor Performance; Pyrroles; Rats; Rats, Long-Evans; Reaction Time; Receptor, Endothelin A; Time Factors; Zidovudine | 2010 |